Prognostic significance of PIK3CA mutation in stage IIB to IVA cervical cancers treated by concurrent chemoradiotherapy with weekly cisplatin

Published 2018 View Full Article

Authors

Keywords

Journal

MEDICINE

Volume 97, Issue 31, Pages e11392

Publisher

Ovid Technologies (Wolters Kluwer Health)

Online

2018-08-03

DOI

10.1097/md.0000000000011392

Ask authors/readers for more resources

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started

MEDICINE

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Publish scientific posters with Peeref

Ask a Question. Answer a Question.